APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory and Antipyretic Granules

Compare research editions
View pricing & licenses

Selected research

Industry Research

Anti-inflammatory and Antipyretic Granules Industry Research Report 2026

27 December 2025138 pages

Choose your research edition.

Industry ResearchAnti-inflammatory and Antipyretic Granules Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory and Antipyretic Granules Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory and Antipyretic Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory and Antipyretic Granules Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory and Antipyretic Granules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Anti-inflammatory and Antipyretic Granules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Anti-inflammatory and Antipyretic Granules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Anti-inflammatory and Antipyretic Granules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Anti-inflammatory and Antipyretic Granules include Dong'e Ejiao Co., Ltd., Guangdong Baihe Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Hebei Tiancheng Pharmaceutical Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Hubei Nordeson Pharmaceutical Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. and Liaoning Xingao Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Anti-inflammatory and Antipyretic Granules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Anti-inflammatory and Antipyretic Granules Market by Company

Dong'e Ejiao Co., Ltd.

Guangdong Baihe Pharmaceutical Co., Ltd.

Guangxi Tiantianle Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hubei Dongxin Pharmaceutical Co., Ltd.

Hubei Nordeson Pharmaceutical Co., Ltd.

Jilin Xianfeng Technology Pharmaceutical Co., Ltd.

Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.

Liaoning Xingao Pharmaceutical Co., Ltd.

Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.

Shaanxi Buchang Pharmaceutical Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Shenyang Junyuan Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

Yunnan Longfa Pharmaceutical Co., Ltd.

Anti-inflammatory and Antipyretic Granules Segment by Type

Pack of 10

Pack of 16

Anti-inflammatory and Antipyretic Granules Segment by Application

Online Sales

Offline Sales

Anti-inflammatory and Antipyretic Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory and Antipyretic Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory and Antipyretic Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory and Antipyretic Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Anti-inflammatory and Antipyretic Granules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Anti-inflammatory and Antipyretic Granules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Anti-inflammatory and Antipyretic Granules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-inflammatory and Antipyretic Granules Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Anti-inflammatory and Antipyretic Granules Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Manufacturers (2021-2026) Table 8. Global Anti-inflammatory and Antipyretic Granules Revenue of Manufacturers (2021-2026) Table 9. Global Anti-inflammatory and Antipyretic Granules Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Anti-inflammatory and Antipyretic Granules Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Anti-inflammatory and Antipyretic Granules Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Anti-inflammatory and Antipyretic Granules, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Anti-inflammatory and Antipyretic Granules, Product Type & Application Table 14. Global Anti-inflammatory and Antipyretic Granules Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Anti-inflammatory and Antipyretic Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Dong'e Ejiao Co., Ltd. Company Information Table 19. Dong'e Ejiao Co., Ltd. Business Overview Table 20. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 22. Dong'e Ejiao Co., Ltd. Recent Developments Table 23. Guangdong Baihe Pharmaceutical Co., Ltd. Company Information Table 24. Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview Table 25. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 27. Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments Table 28. Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information Table 29. Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview Table 30. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 32. Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments Table 33. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 34. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 35. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 37. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments Table 38. Hubei Dongxin Pharmaceutical Co., Ltd. Company Information Table 39. Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview Table 40. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 42. Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments Table 43. Hubei Nordeson Pharmaceutical Co., Ltd. Company Information Table 44. Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview Table 45. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 47. Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments Table 48. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information Table 49. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview Table 50. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 52. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments Table 53. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information Table 54. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview Table 55. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 57. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments Table 58. Liaoning Xingao Pharmaceutical Co., Ltd. Company Information Table 59. Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview Table 60. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 62. Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments Table 63. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information Table 64. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview Table 65. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 67. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments Table 68. Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information Table 69. Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview Table 70. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 72. Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments Table 73. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 74. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 75. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 77. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments Table 78. Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information Table 79. Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview Table 80. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 82. Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments Table 83. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information Table 84. Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview Table 85. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 87. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments Table 88. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 89. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 90. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 92. Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments Table 93. Yunnan Baiyao Group Co., Ltd. Company Information Table 94. Yunnan Baiyao Group Co., Ltd. Business Overview Table 95. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 97. Yunnan Baiyao Group Co., Ltd. Recent Developments Table 98. Yunnan Longfa Pharmaceutical Co., Ltd. Company Information Table 99. Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview Table 100. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 102. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments Table 103. Global Anti-inflammatory and Antipyretic Granules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026) & (K Units) Table 105. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021-2026) Table 106. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2027-2032) & (K Units) Table 107. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2027-2032) Table 108. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021-2026) Table 110. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2027-2032) Table 112. North America Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 114. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 115. North America Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Anti-inflammatory and Antipyretic Granules Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 119. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 120. Europe Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Anti-inflammatory and Antipyretic Granules Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 129. South America Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 130. South America Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Anti-inflammatory and Antipyretic Granules Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 138. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 139. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2026) Table 140. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2027-2032) Table 141. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2026) Table 144. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2027-2032) Table 145. Global Anti-inflammatory and Antipyretic Granules Price by Type (2021-2026) & (US$/Unit) Table 146. Global Anti-inflammatory and Antipyretic Granules Price by Type (2027-2032) & (US$/Unit) Table 147. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 148. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 149. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2026) Table 150. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2027-2032) Table 151. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2026) Table 154. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2027-2032) Table 155. Global Anti-inflammatory and Antipyretic Granules Price by Application (2021-2026) & (US$/Unit) Table 156. Global Anti-inflammatory and Antipyretic Granules Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Anti-inflammatory and Antipyretic Granules Distributors List Table 160. Anti-inflammatory and Antipyretic Granules Customers List Table 161. Anti-inflammatory and Antipyretic Granules Industry Trends Table 162. Anti-inflammatory and Antipyretic Granules Industry Drivers Table 163. Anti-inflammatory and Antipyretic Granules Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Anti-inflammatory and Antipyretic Granules Product Image Figure 5. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Anti-inflammatory and Antipyretic Granules Market Size (2021-2032) & (US$ Million) Figure 7. Global Anti-inflammatory and Antipyretic Granules Sales (2021-2032) & (K Units) Figure 8. Global Anti-inflammatory and Antipyretic Granules Average Price (US$/Unit) & (2021-2032) Figure 9. Pack of 10 Product Image Figure 10. Pack of 16 Product Image Figure 11. Online Sales Product Image Figure 12. Offline Sales Product Image Figure 13. Global Anti-inflammatory and Antipyretic Granules Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Anti-inflammatory and Antipyretic Granules, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Anti-inflammatory and Antipyretic Granules Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Anti-inflammatory and Antipyretic Granules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Anti-inflammatory and Antipyretic Granules Sales by Region in 2025 Figure 19. Global Anti-inflammatory and Antipyretic Granules Revenue by Region in 2025 Figure 20. North America Anti-inflammatory and Antipyretic Granules Market Size by Country in 2025 Figure 21. North America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 22. North America Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021-2032) Figure 23. United States Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Anti-inflammatory and Antipyretic Granules Market Size by Country in 2025 Figure 27. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 28. Europe Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021-2032) Figure 29. Germany Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Anti-inflammatory and Antipyretic Granules Market Size by Country in 2025 Figure 40. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021-2032) Figure 42. China Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Anti-inflammatory and Antipyretic Granules Market Size by Country in 2025 Figure 51. South America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 52. South America Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021-2032) Figure 53. Brazil Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country in 2025 Figure 57. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021-2032) Figure 59. Egypt Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2032) Figure 65. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2032) Figure 66. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Type (2021-2032) Figure 67. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2032) Figure 68. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2032) Figure 69. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Application (2021-2032) Figure 70. Anti-inflammatory and Antipyretic Granules Value Chain Figure 71. Anti-inflammatory and Antipyretic Granules Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges

Scope & coverage.

Types
  • Pack of 10
  • Pack of 16
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Dong'e Ejiao Co., Ltd.
  • Guangdong Baihe Pharmaceutical Co., Ltd.
  • Guangxi Tiantianle Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hubei Dongxin Pharmaceutical Co., Ltd.
  • Hubei Nordeson Pharmaceutical Co., Ltd.
  • Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  • Liaoning Xingao Pharmaceutical Co., Ltd.
  • Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  • Shaanxi Buchang Pharmaceutical Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Shenyang Junyuan Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Yunnan Longfa Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Anti-inflammatory and Antipyretic Granules Market Size (2021-2032)
  4. 2.2.2 Global Anti-inflammatory and Antipyretic Granules Sales (2021-2032)
  5. 2.2.3 Global Anti-inflammatory and Antipyretic Granules Market Average Price (2021-2032)
  6. 2.3 Anti-inflammatory and Antipyretic Granules by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pack of 10
  9. 2.3.3 Pack of 16
  10. 2.4 Anti-inflammatory and Antipyretic Granules by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Online Sales
  13. 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Anti-inflammatory and Antipyretic Granules Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Anti-inflammatory and Antipyretic Granules Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Anti-inflammatory and Antipyretic Granules Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Anti-inflammatory and Antipyretic Granules Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Anti-inflammatory and Antipyretic Granules Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Anti-inflammatory and Antipyretic Granules, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Anti-inflammatory and Antipyretic Granules, Product Type & Application
  8. 3.8 Global Manufacturers of Anti-inflammatory and Antipyretic Granules, Established Date
  9. 3.9 Global Anti-inflammatory and Antipyretic Granules Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Dong'e Ejiao Co., Ltd.
  2. 4.1.1 Dong'e Ejiao Co., Ltd. Company Information
  3. 4.1.2 Dong'e Ejiao Co., Ltd. Business Overview
  4. 4.1.3 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  6. 4.1.5 Dong'e Ejiao Co., Ltd. Recent Developments
  7. 4.2 Guangdong Baihe Pharmaceutical Co., Ltd.
  8. 4.2.1 Guangdong Baihe Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  12. 4.2.5 Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Guangxi Tiantianle Pharmaceutical Co., Ltd.
  14. 4.3.1 Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  18. 4.3.5 Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Hebei Tiancheng Pharmaceutical Co., Ltd.
  20. 4.4.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  24. 4.4.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Hubei Dongxin Pharmaceutical Co., Ltd.
  26. 4.5.1 Hubei Dongxin Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  30. 4.5.5 Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Hubei Nordeson Pharmaceutical Co., Ltd.
  32. 4.6.1 Hubei Nordeson Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  36. 4.6.5 Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  38. 4.7.1 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  42. 4.7.5 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  44. 4.8.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  48. 4.8.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Liaoning Xingao Pharmaceutical Co., Ltd.
  50. 4.9.1 Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  54. 4.9.5 Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  56. 4.10.1 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  60. 4.10.5 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Shaanxi Buchang Pharmaceutical Co., Ltd.
  62. 4.11.1 Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  66. 4.11.5 Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  68. 4.12.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  72. 4.12.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Shenyang Junyuan Pharmaceutical Co., Ltd.
  74. 4.13.1 Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  78. 4.13.5 Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Sichuan Kelun Pharmaceutical Co., Ltd.
  80. 4.14.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  84. 4.14.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Sichuan Luye Pharmaceutical Co., Ltd.
  86. 4.15.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  90. 4.15.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Yunnan Baiyao Group Co., Ltd.
  92. 4.16.1 Yunnan Baiyao Group Co., Ltd. Company Information
  93. 4.16.2 Yunnan Baiyao Group Co., Ltd. Business Overview
  94. 4.16.3 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  96. 4.16.5 Yunnan Baiyao Group Co., Ltd. Recent Developments
  97. 4.17 Yunnan Longfa Pharmaceutical Co., Ltd.
  98. 4.17.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  102. 4.17.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
5 Global Anti-inflammatory and Antipyretic Granules Market Scenario by Region
  1. 5.1 Global Anti-inflammatory and Antipyretic Granules Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021-2032
  3. 5.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021-2026
  4. 5.2.2 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2027-2032
  5. 5.3 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021-2032
  6. 5.3.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021-2026
  7. 5.3.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2027-2032
  8. 5.4 North America Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
  9. 5.4.1 North America Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  11. 5.4.3 North America Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
  16. 5.5.1 Europe Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  18. 5.5.3 Europe Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
  41. 5.7.1 South America Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  43. 5.7.3 South America Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  2. 6.1.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2032)
  4. 6.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  5. 6.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Anti-inflammatory and Antipyretic Granules Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  2. 7.1.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2032)
  4. 7.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  5. 7.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Anti-inflammatory and Antipyretic Granules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Anti-inflammatory and Antipyretic Granules Value Chain Analysis
  2. 8.1.1 Anti-inflammatory and Antipyretic Granules Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Anti-inflammatory and Antipyretic Granules Production Mode & Process
  5. 8.2 Anti-inflammatory and Antipyretic Granules Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Anti-inflammatory and Antipyretic Granules Distributors
  8. 8.2.3 Anti-inflammatory and Antipyretic Granules Customers
9 Global Anti-inflammatory and Antipyretic Granules Analyzing Market Dynamics
  1. 9.1 Anti-inflammatory and Antipyretic Granules Industry Trends
  2. 9.2 Anti-inflammatory and Antipyretic Granules Industry Drivers
  3. 9.3 Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges
  4. 9.4 Anti-inflammatory and Antipyretic Granules Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst